Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) is hosting a Research
& Development (R&D) Day today in New York to discuss its
emerging pipeline of RNAi therapeutics that leverage its proprietary
Targeted RNAi Molecule Platform (TRiM™) platform. The event will feature
presentations by Arrowhead’s management team and Ira Goldberg, M.D.,
the Clarissa and Edgar Bronfman, Jr. Professor of Endocrinology, and the
Director of the Division of Endocrinology, Diabetes, and Metabolism at
NYU Langone Medical Center.
Presentations will begin at 8:30 a.m. EDT. A live and archived webcast of the event may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.
https://www.businesswire.com/news/home/20191018005154/en/Arrowhead-Pharmaceuticals-Hosts-Day-Emerging-Pipeline-RNAi
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.